These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 4082353
1. [Cardiovascular complications, lipoprotein metabolism and oral contraceptives]. Gagné C. Union Med Can; 1985 Oct; 114(10):865-71. PubMed ID: 4082353 [No Abstract] [Full Text] [Related]
2. [Cardiovascular side-effects of oral contraceptives with special regard to metabolism, lipoproteins and their role in the pathogenesis of vascular complications (author's transl)]. Ludwig H. Schweiz Rundsch Med Prax; 1981 Mar 24; 70(13):549-53. PubMed ID: 7232305 [Abstract] [Full Text] [Related]
3. Oral contraceptives and cardiovascular disease (second of two parts). Stadel BV. N Engl J Med; 1981 Sep 17; 305(12):672-7. PubMed ID: 7022211 [No Abstract] [Full Text] [Related]
4. [Metabolic and vascular consequences of hormonal contraception in non-diabetics]. Basdevant A, Guy-Grand B. Journ Annu Diabetol Hotel Dieu; 1983 Sep 17; ():223-37. PubMed ID: 6358613 [No Abstract] [Full Text] [Related]
5. Oral contraceptives and the risk of cardiovascular disease. Med Lett Drugs Ther; 1983 Jul 22; 25(640):69-70. PubMed ID: 6865850 [Abstract] [Full Text] [Related]
6. [Estrogens, progestins and blood lipids]. Tikkanen MJ. Duodecim; 1984 Jul 22; 100(22):1500-3. PubMed ID: 6518995 [Abstract] [Full Text] [Related]
11. Oral contraceptives and cardiovascular disease (first of two parts). Stadel BV. N Engl J Med; 1981 Sep 10; 305(11):612-8. PubMed ID: 7022208 [No Abstract] [Full Text] [Related]
12. [Drug-induced hyperglycemia as a possible cardiovascular risk factor]. Mammarella A, Paoletti V, Bucci O, Cavina G, Filippello CP, Iovene A, Mariani AR. Clin Ter; 1988 Mar 31; 124(6):425-33. PubMed ID: 2904845 [No Abstract] [Full Text] [Related]
13. Comparative review of third-generation progestins. Kafrissen ME, Corson SL. Int J Fertil Menopausal Stud; 1993 Mar 31; 38 Suppl 3():103-13. PubMed ID: 8260967 [No Abstract] [Full Text] [Related]
14. [Contraceptive pills; their effect on lipid and carbohydrate metabolism and on the cardiocirculatory system. Epidemiological and experimental aspects]. Lederer J, Vastesaeger M. Brux Med; 1977 May 31; 57(5):199-214. PubMed ID: 880501 [No Abstract] [Full Text] [Related]
15. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Contraception; 1998 May 31; 57(5):315-24. PubMed ID: 9673838 [Abstract] [Full Text] [Related]
16. [Risk of thrombophlebitis during hormonal contraception]. Ludwig H. Ther Umsch; 1971 Aug 31; 28(8):516-21. PubMed ID: 5119110 [No Abstract] [Full Text] [Related]
17. [Estrogens and cardiovascular diseases: should current guidelines be changed?]. Beller F, Theiss W. Zentralbl Gynakol; 1994 Aug 31; 116(8):441-8. PubMed ID: 7941812 [Abstract] [Full Text] [Related]
18. [Oral contraceptives and cardiovascular disease--aspects of lipid metabolism]. Crona N, Silfverstolpe G. Lakartidningen; 1984 Feb 08; 81(6):425-7. PubMed ID: 6700305 [Abstract] [Full Text] [Related]